Polymer Microcarrier Tissue Scaffolds for Complex 3D Geometry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing tissue scaffolds are limited by their ability to form complex geometries, require complex and time-consuming manual work, and can lead to immunogenic and inflammatory reactions due to residual materials, limiting their clinical applicability and effectiveness.
Innovation Solution
A method involving anchorage-dependent cells cultured with biocompatible hydrogel beads to produce extracellular matrix, followed by mechanical conditioning and decellularization, resulting in a scaffold that mimics native extracellular matrix and can be repopulated by host cells, using alginate beads with cell-adhesion ligands and controlled degradation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Shape
If tubular PGA scaffolds are used with manual wrapping and seam construction, then simple geometric grafts can be produced, but complex three-dimensional tissue geometries cannot be achieved
Solution Approach 1:
The scaffold is segmented into multiple PGA sheets that are stacked and joined together. Each sheet can be independently manufactured with consistent geometry, and the stacking approach enables complex 3D shapes while maintaining manufacturing simplicity through standardized sheet production and automated joining processes
Solution Approach 2:
The invention transitions from two-dimensional tubular wrapping to three-dimensional stacked sheet construction. By adding the stacking dimension, complex geometries including curved surfaces and variable thickness regions can be achieved while maintaining consistent fiber orientation and density through controlled sheet lamination
2Productivity
If manual wrapping procedures are used to construct tubular PGA scaffolds, then construction is possible, but time-consuming manual work and product variation occur
Solution Approach 1:
PGA sheets are pre-manufactured with controlled fiber orientation, density, and geometric features before assembly. This preliminary preparation enables automated stacking and joining processes, eliminating time-consuming manual wrapping while ensuring consistent product quality through standardized sheet production
Solution Approach 2:
The manual mechanical wrapping process is replaced with an automated sheet stacking and joining system. Machines precisely position and bond pre-fabricated PGA sheets, dramatically reducing construction time and eliminating human-induced variations in seam quality and fiber alignment
3Object-affected harmful factors
If PGA degradation is accelerated through treatment and cell degradation, then scaffold removal is facilitated, but residual PGA matrix presents immunogenic and inflammatory reactions
Solution Approach 1:
The degradation parameters of PGA are modified through controlled hydrolysis treatment that creates predictable degradation profiles. The sheet structure and fiber orientation are optimized to control degradation rate, allowing complete breakdown into non-immunogenic byproducts while maintaining structural integrity during the required functional period
Solution Approach 2:
The PGA scaffold is designed as a temporary support structure that is completely degraded and discarded after fulfilling its structural role. The degradation process is controlled to ensure complete breakdown before tissue maturation, eliminating residual immunogenic material while the scaffold provides necessary mechanical support during tissue engineering
4Length of stationary object
If macroporous PGA membranes are used as substrates, then cell culture is enabled, but construct thickness is limited
Solution Approach 1:
The thick construct is segmented into multiple thinner PGA sheets stacked together. Each sheet maintains appropriate porosity for cell culture, while the stacked configuration achieves the required overall thickness. Interstitial spaces between sheets provide nutrient diffusion pathways, enabling cell viability throughout the entire construct thickness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the production of complex three-dimensional tissue scaffolds that are non-immunogenic and can be repopulated, enhancing clinical applicability and safety by reducing immunogenic and inflammatory risks.
Implementation Method 1
The biocompatible hydrogel beads support attachment of the first group of cells
Implementation Method 2
culturing the first cell-bead mixture to produce extracellular matrix thereby obtaining a first tissue scaffold
Implementation Method 3
subjecting the first tissue scaffold to decellularization thereby obtaining a second tissue scaffold
Implementation Method 4
the biocompatible hydrogel beads are degradable or dissolvable
Data Source
Figure 1a~1c
Figure 2a~2d
Figure 2e~2g
AI summary
The present invention relates to regenerative medicine in general, in particular tissue engineering. The present invention provides improved manufacturing methodologies which enables production of complex three-dimensional tissue scaffolds. The scaffolds are essentially non-immunogenic when implanted into a subject, mimic native extracellular matrix and may be repopulated and modulated by host cells thereby becoming living tissues.